Ośrodek Badania Alergenów Środowiskowychsp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2014-12-09
Share capital
50,000.00 PLN
Registered address
ul. Tadeusza Kościuszki 76, 05-080 Izabelin C, Poland
Electronic delivery address
AE:PL-39297-76886-VUEWG-27
Financials
Revenue history (in k)
From the notes
| Current income tax (CIT due) | $1,254 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 37 days late).
- 202512/07/2026
- 202430/06/2025
- 202330/03/2024
- 202209/07/2023
- 202121/08/2022
- 202003/05/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Industry · Other research and experimental development on natural sciences and engineering582 / 1,565
Top 37%
Results vs industry
Revenue
This companyUSD 166.67kMedianUSD 73.26kAverageUSD 3.23m
Net profit
This companyUSD 21.06kMedianUSD 69.70AverageUSD 82.18k
Operating costs
This companyUSD 143.89kMedianUSD 75.78kAverageUSD 3.04m
Assets
This companyUSD 114.23kMedianUSD 119.88kAverageUSD 3.90m
Industry
Authorized Representatives
Agnieszka Anna Lipiec – Management Board Member
Piotr Rapiejko – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Agnieszka Anna Lipiecage 61 | 25 | $6,753.11 | 50% |
Piotr Rapiejkoage 62 | 25 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,619$1,619 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,619$1,619 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,619$1,619 | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Pharmaxi Polandsp. z o.o. | $152,292.34 | pharmaxi.com.ua | ||
| Omega Innovationssp. z o.o. | $110,004.52 | omegainnovations.eu | ||
| TriggoS.A. | $122,470.02 | triggo.city | ||
| Cezamat Pwsp. z o.o. | $119,656.05 | cezamat.eu | ||
| Recometalsp. z o.o. | $114,425.74 | recometal.pl | ||
| Bacteromicsp. z o.o. | $112,732.71 | bacteromic.com | ||
| Countess Laboratoriessp. z o.o. | $99,221.13 | countess.pl | ||
| CBK Med Clinicsp. z o.o. | $91,889.00 | cbkmedclinic.pl | ||
| CPJS - Centrum Promocji Jakości Stalisp. z o.o. | $90,239.54 | epstal.pl | ||
| Solhotairsp. z o.o. | $6,062.47 | solhotair.pl |
FAQ
The main business activity of Ośrodek Badania Alergenów Środowiskowych focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on December 9, 2014.
The headquarters is located at: ul. Tadeusza Kościuszki 76, 05-080 Izabelin C.
The management board consists of: Agnieszka Anna Lipiec (Member of the Management Board) and Piotr Rapiejko (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $146,572, representing a decrease of 8.7% compared to 2023.
No, the company recorded a net loss of $6,891 in 2024.
The largest operating cost category falls under employee remuneration. This category amounted to $67,047 in 2024, representing 44% of all operating expenses.
Last updated: 2026-07-16
